198 related articles for article (PubMed ID: 32969473)
1. Angiotensin II enhances the proliferation of Natural Killer/T-cell lymphoma cells via activating PI3K/Akt signaling pathway.
Zhang GH; Miao FA; Xu JG; Zhang Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969473
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
Giani JF; Gironacci MM; Muñoz MC; Peña C; Turyn D; Dominici FP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1154-63. PubMed ID: 17496209
[TBL] [Abstract][Full Text] [Related]
4. A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells.
Yano N; Suzuki D; Endoh M; Zhao TC; Padbury JF; Tseng YT
J Biol Chem; 2007 Jun; 282(26):18819-30. PubMed ID: 17493931
[TBL] [Abstract][Full Text] [Related]
5. Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway.
Bu L; Qu S; Gao X; Zou JJ; Tang W; Sun LL; Liu ZM
Endocrine; 2011 Apr; 39(2):139-47. PubMed ID: 21188549
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Oya M
Prostate; 2011 Oct; 71(14):1510-7. PubMed ID: 21321983
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of the Ang II/AT1 receptor may compensate for the loss of gastric antrum ICC via the PI3k/Akt signaling pathway in STZ-induced diabetic mice.
Zhang CM; Huang X; Lu HL; Meng XM; Liu DH; Kim YC; Xu WX
Mol Cell Endocrinol; 2016 Mar; 423():77-86. PubMed ID: 26773730
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II promotes differentiation of mouse embryonic stem cells to smooth muscle cells through PI3-kinase signaling pathway and NF-κB.
Zheng X; Wu Y; Zhu L; Chen Q; Zhou Y; Yan H; Chen T; Xiao Q; Zhu J; Zhang L
Differentiation; 2013 Jan; 85(1-2):41-54. PubMed ID: 23337518
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II promotes the progression of human gastric cancer.
Huang MM; Guo AB; Sun JF; Chen XL; Yin ZY
Mol Med Rep; 2014 Mar; 9(3):1056-60. PubMed ID: 24424956
[TBL] [Abstract][Full Text] [Related]
10. Ang II-AT1R increases cell migration through PI3K/AKT and NF-κB pathways in breast cancer.
Zhao Y; Wang H; Li X; Cao M; Lu H; Meng Q; Pang H; Li H; Nadolny C; Dong X; Cai L
J Cell Physiol; 2014 Nov; 229(11):1855-62. PubMed ID: 24692224
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
13. [Bortezomib Inhibits Extranodal Natural Killer/T Cell Lymphoma, Nasal Type by Targeting NF-κB Signaling Pathway].
Li JH; Zhang L; Feng Y; Zou LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):311-316. PubMed ID: 31631595
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
15. KIR2DL4 promotes the proliferation of RCC cell associated with PI3K/Akt signaling activation.
Ding XF; Chen J; Ma HL; Liang Y; Wang YF; Zhang HT; Li X; Chen G
Life Sci; 2022 Mar; 293():120320. PubMed ID: 35063466
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
17. Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury.
Wang J; Fu D; Senouthai S; You Y
Mol Med Rep; 2019 Dec; 20(6):5134-5144. PubMed ID: 31638199
[TBL] [Abstract][Full Text] [Related]
18. The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.
Liu R; Liu D; Trink E; Bojdani E; Ning G; Xing M
J Clin Endocrinol Metab; 2011 Apr; 96(4):E577-85. PubMed ID: 21289267
[TBL] [Abstract][Full Text] [Related]
19. Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation.
Dugourd C; Gervais M; Corvol P; Monnot C
Hypertension; 2003 Apr; 41(4):882-90. PubMed ID: 12623864
[TBL] [Abstract][Full Text] [Related]
20. GPR174 suppression attenuates retinopathy in angiotensin II (Ang II)-treated mice by reducing inflammation via PI3K/AKT signaling.
Yue J; Zhao X
Biomed Pharmacother; 2020 Feb; 122():109701. PubMed ID: 31918274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
